From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Managing Acute Pain in Patients Who Take Maintenance Opioid Agonists

In an overview of this sometimes difficult situation, reviewers note common misperceptions and provide clinical recommendations.

With the increasing use of buprenorphine for maintenance treatment of opioid dependence, more physicians will encounter patients who take long-term opioid-agonist therapy (methadone or buprenorphine) and who have acute pain. In this review, addiction and pain experts have provided advice on managing this sometimes difficult situation.

The authors note four common misconceptions:

(1) Maintenance opioid agonists provide analgesia. (They do not, because of pharmacokinetic and pharmacodynamic factors.).

(2) Opioid use for acute pain could result in addiction relapse. (No published evidence suggests that this is the case.)

(3) Treatment with opioid analgesics, in addition to maintenance agonists, could cause respiratory and central nervous system depression. (Although this effect is theoretically possible, drug tolerance makes it very unlikely.)

(4) Reports of pain could reflect drug-seeking behavior. (If accompanied by objective findings, acute pain is unlikely to represent manipulation by the patient.)

The authors recommend the following:

  • Reassure the patient that pain will be treated adequately, verify the maintenance dose of the opioid agonist, and continue it.
  • Use short-acting opioids when necessary, in addition to the long-acting maintenance dose, and anticipate the need to use higher doses because of tolerance.
  • Prescribe scheduled rather than as-needed doses.
  • Use of opioids in addition to buprenorphine is complicated, because buprenorphine binds tightly to opioid receptors. Except for cases of mild acute pain of short duration, discontinuing buprenorphine might be required to effectively treat pain with short-acting opioids. In these cases, dose opioids to avoid withdrawal (which might require the addition of methadone) and then to achieve analgesia.

Comment: Expert opinion is particularly useful for a challenging, difficult-to-study clinical problem like pain and addiction.

— Richard Saitz, MD, MPH, FACP, FASAM

Dr. Saitz is affiliated with the same department as the lead author but was not involved in the Annals article.

Published in Journal Watch General Medicine February 7, 2006

Citation(s):

Alford DP et al. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 2006 Jan 17; 144:127-34.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.